As of 2024-12-14, the Relative Valuation of Acutus Medical Inc (AFIB) is (89.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 USD, the upside of Acutus Medical Inc based on Relative Valuation is -99400.3%.
The range of the Relative Valuation is (94.14) - (89.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 41.3x | 38.8x |
| Forward P/E multiples | 29.2x - 35.1x | 31.4x |
| Fair Price | (94.14) - (89.26) | (89.37) |
| Upside | -104701.0% - -99273.0% | -99400.3% |
| Date | P/E |
| 2024-12-11 | -0.03 |
| 2024-12-10 | -0.03 |
| 2024-12-09 | -0.02 |
| 2024-12-06 | -0.03 |
| 2024-12-05 | -0.03 |
| 2024-12-04 | -0.03 |
| 2024-12-03 | -0.02 |
| 2024-12-02 | -0.02 |
| 2024-11-29 | -0.02 |
| 2024-11-27 | -0.03 |
| 2024-11-26 | -0.03 |
| 2024-11-25 | -0.03 |
| 2024-11-22 | -0.03 |
| 2024-11-21 | -0.02 |
| 2024-11-20 | -0.02 |
| 2024-11-19 | -0.03 |
| 2024-11-18 | -0.02 |
| 2024-11-15 | -0.02 |
| 2024-11-14 | -0.02 |
| 2024-11-13 | -0.02 |
| 2024-11-12 | -0.02 |
| 2024-11-11 | -0.03 |
| 2024-11-08 | -0.03 |
| 2024-11-07 | -0.05 |
| 2024-11-06 | -0.05 |
| 2024-11-05 | -0.05 |
| 2024-11-04 | -0.06 |
| 2024-11-01 | -0.06 |
| 2024-10-31 | -0.06 |
| 2024-10-30 | -0.06 |
| 2024-10-29 | -0.06 |
| 2024-10-28 | -0.06 |
| 2024-10-25 | -0.06 |
| 2024-10-24 | -0.06 |
| 2024-10-23 | -0.06 |
| 2024-10-22 | -0.06 |
| 2024-10-21 | -0.06 |
| 2024-10-18 | -0.06 |
| 2024-10-17 | -0.08 |
| 2024-10-16 | -0.07 |
| 2024-10-15 | -0.07 |
| 2024-10-14 | -0.07 |
| 2024-10-11 | -0.06 |
| 2024-10-10 | -0.05 |
| 2024-10-09 | -0.05 |
| 2024-10-08 | -0.04 |
| 2024-10-07 | -0.05 |
| 2024-10-04 | -0.05 |
| 2024-10-03 | -0.04 |
| 2024-10-02 | -0.03 |